TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02744833

Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“The trial was funded in part by a grant; the trial closed when the grant ended.”

The sponsor’s own words in the registry.

Life of this trial

201620172018Registered2016-04-08Started2016-07Stopped2016-11

Vital statistics

Status
Terminated
Phase
Phase 1, Phase 2
Sponsor
GlycoMimetics Incorporated
Sponsor type
Industry
Conditions
Deep Venous Thrombosis
Interventions
GMI-1271; Enoxaparin Sodium (Lovenox®)
Participants
2
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.